181 related articles for article (PubMed ID: 7683635)
1. Demonstration of initiation potential of carcinogens by induction of preneoplastic glutathione S-transferase P-form-positive liver cell foci: possible in vivo assay system for environmental carcinogens.
Tsuda H; Matsumoto K; Ogino H; Ito M; Hirono I; Nagao M; Sato K; Cabral R; Bartsch H
Jpn J Cancer Res; 1993 Mar; 84(3):230-6. PubMed ID: 7683635
[TBL] [Abstract][Full Text] [Related]
2. Enhancing effects of captafol on the development of GST-P-positive liver cell foci in a medium-term bioassay, and protection by L-cysteine of the enhancement in rats.
Kim HC; Cha SW; Song SW; Ha CS; Han SS; Roh JK; Lee YS; Furukawa F; Nishikawa A; Takahashi M
Cancer Lett; 1997 Jan; 111(1-2):15-20. PubMed ID: 9022123
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of nongenotoxic and genotoxic carcinogens on the preneoplastic lesions in the rat liver.
Kim DJ; Lee KK; Hong JT
Arch Pharm Res; 1998 Aug; 21(4):363-9. PubMed ID: 9875460
[TBL] [Abstract][Full Text] [Related]
4. Comparison of initiation potential of 2-amino-3-methylimidazo[4,5-f]quinoline and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in an in vivo carcinogen bioassay system.
Tsuda H; Takahashi S; Yamaguchi S; Ozaki K; Ito N
Carcinogenesis; 1990 Apr; 11(4):549-52. PubMed ID: 2322995
[TBL] [Abstract][Full Text] [Related]
5. Presence of a no-observed effect level for enhancing effects of development of the alpha-isomer of benzene hexachloride (alpha-BHC) on diethylnitrosamine-initiated hepatic foci in rats.
Masuda C; Wanibuchi H; Otori K; Wei M; Yamamoto S; Hiroi T; Imaoka S; Funae Y; Fukushima S
Cancer Lett; 2001 Feb; 163(2):179-85. PubMed ID: 11165752
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of GST-P positive liver cell foci development by a medium-term carcinogenicity bioassay using repeated administration of D-galactosamine.
Kim HC; Lee YS; Furukawa F; Nishikawa A; Takahashi M
Cancer Lett; 1995 Nov; 98(1):71-6. PubMed ID: 8529208
[TBL] [Abstract][Full Text] [Related]
7. Age-dependent induction of preneoplastic liver cell foci by 2-acetylaminofluorene, phenobarbital and acetaminophen in F344 rats initially treated with diethylnitrosamine.
Hasegawa R; Takahashi S; Imaida K; Yamaguchi S; Shirai T; Ito N
Jpn J Cancer Res; 1991 Mar; 82(3):293-7. PubMed ID: 1902451
[TBL] [Abstract][Full Text] [Related]
8. Qualitative and quantitative approaches in the dose-response assessment of genotoxic carcinogens.
Fukushima S; Gi M; Kakehashi A; Wanibuchi H; Matsumoto M
Mutagenesis; 2016 May; 31(3):341-6. PubMed ID: 26152227
[TBL] [Abstract][Full Text] [Related]
9. Medium-term bioassays for carcinogenicity of chemical mixtures.
Ito N; Imaida K; Hirose M; Shirai T
Environ Health Perspect; 1998 Dec; 106 Suppl 6(Suppl 6):1331-6. PubMed ID: 9860889
[TBL] [Abstract][Full Text] [Related]
10. A medium-term rat liver bioassay for rapid in vivo detection of carcinogenic potential of chemicals.
Ito N; Tamano S; Shirai T
Cancer Sci; 2003 Jan; 94(1):3-8. PubMed ID: 12708466
[TBL] [Abstract][Full Text] [Related]
11. Enhancing effects of phenobarbital and 3-methylcholanthrene on GST-P-positive liver cell foci development in a new medium-term rat liver bioassay using D-galactosamine.
Kim HC; Lee YS; Nishikawa A
J Toxicol Environ Health; 1997 Apr; 50(5):519-28. PubMed ID: 9140468
[TBL] [Abstract][Full Text] [Related]
12. Stochastic simulation of hepatic preneoplastic foci development for four chlorobenzene congeners in a medium-term bioassay.
Ou YC; Conolly RB; Thomas RS; Gustafson DL; Long ME; Dobrev ID; Chubb LS; Xu Y; Lapidot SA; Andersen ME; Yang RS
Toxicol Sci; 2003 Jun; 73(2):301-14. PubMed ID: 12700395
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of GST-P positive liver cell foci development by combined treatment of rats with five heterocyclic amines at low doses.
Ito N; Hasegawa R; Shirai T; Fukushima S; Hakoi K; Takaba K; Iwasaki S; Wakabayashi K; Nagao M; Sugimura T
Carcinogenesis; 1991 May; 12(5):767-72. PubMed ID: 2029739
[TBL] [Abstract][Full Text] [Related]
14. Reappraisal of eight representative carcinogenic and non-carcinogenic compounds in a new medium-term rat liver bioassay using D-galactosamine.
Kim HC; Cha SW; Ha CS; Roh JK; Lee YS; Furukawa F; Nishikawa A; Takahashi M
Cancer Lett; 1996 Jun; 104(1):85-90. PubMed ID: 8640751
[TBL] [Abstract][Full Text] [Related]
15. Enhancing effect of various hepatocarcinogens on induction of preneoplastic glutathione S-transferase placental form positive foci in rats--an approach for a new medium-term bioassay system.
Ito N; Tsuda H; Tatematsu M; Inoue T; Tagawa Y; Aoki T; Uwagawa S; Kagawa M; Ogiso T; Masui T
Carcinogenesis; 1988 Mar; 9(3):387-94. PubMed ID: 3345580
[TBL] [Abstract][Full Text] [Related]
16. Concordance of thresholds for carcinogenicity of N-nitrosodiethylamine.
Waddell WJ; Fukushima S; Williams GM
Arch Toxicol; 2006 Jun; 80(6):305-9. PubMed ID: 16308687
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical demonstration of the gap junctional protein connexin 32 and proliferating cell nuclear antigen in glutathione S-transferase placental form-negative lesions of rat liver induced by diethylnitrosamine and clofibrate.
Ito S; Tateno C; Tuda M; Yoshitake A
Toxicol Pathol; 1996; 24(6):690-5. PubMed ID: 8994295
[TBL] [Abstract][Full Text] [Related]
18. A new medium-term bioassay system for detection of environmental carcinogens using diethylnitrosamine-initiated rat liver followed by D-galactosamine treatment and partial hepatectomy.
Ito N; Imaida K; de Camargo JL; Takahashi S; Asamoto M; Tsuda H
Jpn J Cancer Res; 1988 May; 79(5):573-5. PubMed ID: 3136108
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of glutathione S-transferase placental-form positive liver cell foci development by microcystin-LR in aflatoxin B1-initiated rats.
Sekijima M; Tsutsumi T; Yoshida T; Harada T; Tashiro F; Chen G; Yu SZ; Ueno Y
Carcinogenesis; 1999 Jan; 20(1):161-5. PubMed ID: 9934864
[TBL] [Abstract][Full Text] [Related]
20. Lack of carcinogenicity of daminozide, alone or in combination with its contaminant 1,1-dimethylhydrazine, in a medium-term bioassay.
Cabral R; Hakoi K; Hoshiya T; Hasegawa R; Ito N
Teratog Carcinog Mutagen; 1995-1996; 15(6):307-12. PubMed ID: 8732881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
